This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
Generated Narrative: ArtifactAssessment
Resource ArtifactAssessment "179694" Version "3" Updated "2023-12-04 21:36:46+0000"
Profile: Comment
Artifact URL: https://fevir.net/resources/ArtifactAssessment/179694
Artifact Description: This example of a Comment Profile shows a comment about another Resource (Guideline Profile) in which the commenter is not the author of the Resource commented upon.
Artifact Author: Joanne Dehnbostel:
modifierExtension[http://hl7.org/fhir/StructureDefinition/artifact-status]
identifier: FEvIR Object Identifier: 179694
title: Comment on Guideline: ADA 2021 Standards of Medical Care 8. Obesity Management for the Treatment of Type 2 Diabetes by Joanne Dehnbostel 2023-11-28T15:19:01.266Z
citeAs: Comment on Guideline: ADA 2021 Standards of Medical Care 8. Obesity Management for the Treatment of Type 2 Diabetes by Joanne Dehnbostel 2023-11-28T15:19:01.266Z [ArtifactAssessment]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179694. Revised 2023-11-28. Available at: https://fevir.net/resources/ArtifactAssessment/179694. Computable resource at: https://fevir.net/resources/ArtifactAssessment/179694.
Summary | FreeToShare |
It is not clear whether the reference to Asian Americans includes native Hawaiians or Pacific Islanders. | true |